Kosuke Iwatani
Papers
2
Total Citations
4
H-Index
1
About
Kosuke Iwatani is a Japanese urologic oncologist whose research focuses on optimizing surgical outcomes for high-risk prostate cancer, particularly through robot-assisted radical prostatectomy (RARP). His major contributions center on evaluating neoadjuvant therapies—both hormonal and chemohormonal—prior to RARP, with the goal of reducing biochemical recurrence in patients with high- or very-high-risk disease. In a 2025 retrospective multicenter study using propensity score-matched analysis, Iwatani demonstrated the efficacy of neoadjuvant hormonal therapy in this context, while another key paper compared neoadjuvant chemohormonal therapy against extended pelvic lymph node dissection (ePLND), addressing a critical debate in surgical oncology. Though his work is early-stage, with citations currently in the single digits, these studies represent important steps toward personalizing treatment for aggressive prostate cancer. Iwatani’s research bridges the gap between systemic therapy and surgical precision, offering evidence that may shape future guidelines. His focus on Japanese patient populations adds valuable regional data to the global literature, making him a rising voice in urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2